Open AccessTroponin T in COVID-19 hospitalized patients: Kinetics matter
Author(s) -
MariaLuiza Luchian,
Andreea Motoc,
Stijn Lochy,
Julien Magné,
Bram Roosens,
Dries Belsack,
Karen Van den Bussche,
Berlinde von Kemp,
Xavier Galloo,
Clara François,
Esther Scheirlynck,
Sven Boeckstaens,
Tom De Potter,
Lucie Seyler,
Johan Van Laethem,
Sophie Hennebicq,
Caroline Weytjens,
Steven Droogmans,
Bernard Cosyns
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0104
Subject(s) - mace , medicine , hazard ratio , troponin t , confidence interval , cardiology , proportional hazards model , troponin , covid-19 , clinical endpoint , myocardial infarction , disease , percutaneous coronary intervention , clinical trial , infectious disease (medical specialty)
Coronavirus disease 2019 (COVID-19) emerged as a worldwide health crisis, overwhelming healthcare systems. Elevated cardiac troponin T (cTn T) at admission was associated with increased in-hospital mortality. However, data addressing the role of cTn T in major adverse cardiovascular events (MACE) in COVID-19 are scarce. Therefore, we assessed the role of baseline cTn T and cTn T kinetics for MACE and in-hospital mortality prediction in COVID-19.